accumulation in adipocytes (22, 23) , but the mechanism(s) by which this occurs and its implications for whole-body energetics remain controversial. Furthermore, the effects of 10E,12Z-CLA on lipid metabolic functions in other target tissues such as the liver and skeletal muscle are also disputed. This study was performed to determine the precise mechanism(s) involved in reduced adipocyte lipid storage by 10E,12Z-CLA, and potential mechanisms by which it might have adverse effects. Understanding these mechanisms is crucial to resolving the debate on whether or not commercial CLA supplements are safe for human consumption.
An emerging hypothesis regarding the adipocyte-specific effects of 10E,12Z-CLA suggests that it reduces lipid accumulation by increasing energy expenditure. Recent studies have proposed that 10E,12Z-CLA increases lipolysis and/or oxidation of stored triglyceride (24) (25) (26) , thereby reducing the amount of neutral lipid stored in adipose tissue. Therefore, we hypothesized that 10E,12Z-CLA promotes the mobilization of stored triglyceride from adipocytes into fatty acids, to be utilized as an energy source for other organ systems or by the adipocyte itself. Using an established in vitro model of murine adipocyte biology, we have shown that 10E,12Z-CLA reduces lipid accumulation by stimulating lipolysis and increasing fatty acid oxidation, as well as decreasing glucose uptake and consumption. As a consequence of enhanced fatty acid oxidation, 10E,12Z-CLA also induced mitochondrial reactive oxygen species (ROS) production and pro-inflammatory cytokine/chemokine gene expression in the adipocyte.
Materials and Methods

Preparation of Fatty Acid-Albumin Complexes
Conjugated linoleic acid isomers were obtained from Nu-Check Prep, and palmitic acid was obtained from Sigma-Aldrich. Free fatty acids (FFA) were conjugated to fatty acid-and endotoxin-free albumin (Sigma) at a 3:1 (FFA:albumin) molar ratio in 100 mM NaOH as described previously (27) . Control fatty by guest, on November 10, 2017 www.jlr.org
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Total RNA (2 µg) from treated cells was reverse-transcribed into cDNA using reagents from Invitrogen and Promega. Real time RT-PCR was performed using an ABI 7900HT system. Target genes were amplified using commercial TaqMan probe sets (Applied Biosystems), with beta 2 microglobulin (B2M) and GAPDH serving as endogenous housekeeping controls. Gene expression was quantified using the ΔΔ C T method and presented as a fold change from control cells cultured in 5 mM glucose-containing DMEM.
Fatty Acid Oxidation Assay
Adipocytes were treated with fatty acids in 25 mM glucose for 7 days, and fatty acid oxidation was quantified as described previously (28) . Briefly, cells were washed, detached from culture plates and transferred to plastic vials. Each vial contained an open smaller inner vial fitted with Whatman filter paper, not in direct contact with the cell suspension. 14 C-Oleate (0.5 µCi) was conjugated to fatty acidfree albumin as described above and added to each cell sample at a final concentration of 250 µM. Vials were sealed tightly and incubated for 3 hours at 37ºC. Without opening the vials, 100 mM hyamine hydroxide was injected into the inner vial containing the filter paper, and 100 mM hydrogen chloride was injected into the outer cell suspension. Vials were incubated overnight at 37ºC to allow 14 C-CO 2 released from adipocytes become attracted to the hyamine hydroxide-soaked filter paper, the filter paper was removed, and adsorbed 14 C-CO 2 was quantified using a scintillation counter.
Lipolysis Assay
Basal (unstimulated) lipolysis rates of 3T3-L1 adipocytes were estimated by quantifying glycerol released into the culture medium after 7 days of treatment as described in (29) . In addition, stimulated lipolysis was also measured from 3T3-L1 adipocytes that had been treated with fatty acids for 7 days. Briefly, adipocytes were washed and incubated with 2% fatty acid-free albumin and 10 μM isoproterenol for 2 hours, and glycerol released into the culture medium was quantified as described previously (30) .
Fatty acid uptake assay
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Following the 7-day fatty acid treatment protocol, 3T3-L1 adipocytes were exposed to 0.5 μCi
14
C-Oleate conjugated to fatty acid free albumin for 18 hours. Cells were thoroughly washed, and half were lysed in 1% NP-40 for immediate scintillation counting and the other half were scraped into vials for 14 CO 2 capture, as described in the fatty acid oxidation section. Total fatty acid uptake was calculated by adding total counts from cell lysates and total counts from captured 14 CO 2 .
Glucose Uptake, Consumption, and Insulin Signaling Assays
For 2-deoxyglucose uptake assays, treated adipocytes were serum-starved overnight, washed with KrebsRingers-HEPES (KRH) buffer, and incubated for 2 hours in KRH + 1% fatty acid-free albumin, as described previously (31) . After exposing the cells to 100 nM insulin for 15 minutes, 0.5 µCi 3 H-2-deoxyglucose was added for 10 minutes. Cytochalasin B (10 µM, Sigma Aldrich) was included as a negative control to prevent glucose uptake, and was also used to stop the assay. Cells were lysed in 0.1 M NaOH, and cell lysates were subjected to liquid scintillation counting and protein quantification. 3 H-2-deoxyglucose uptake was calculated as counts per minute per mg total protein. To evaluate glucose consumption, glucose in the cell culture supernatant was measured every 24 hours using a Medline
OptimumEZ glucometer for the duration of the 7-day treatment. Measurements were made immediately before the daily media change and subtracted from the baseline glucose content of complete cell-free medium to calculate glucose consumption. Only measurements from high glucose-treated cells were taken. To evaluate Glut4 and insulin signaling pathways, treated adipocytes were washed and lysed in Buffer A (1 mM NaHCO 3 , 5 mM MgCl 2 , 50 mM Tris-HCl, 10 mM EGTA, 2 mM EDTA, 25 µg/mL leupeptin, 10 mM benzamidine, 1 mM DTT, and 1 mM PMSF, pH 7.4). For complete cell lysis, cells were passed through a 26g needle 5 times and incubated for 30 minutes on ice. Cell lysates were ultracentrifuged at 100,000g for 1 hour at 4ºC and the supernatant (cytosolic fraction) was saved for
Western blot analysis of P-Akt (Cell Signaling) and Glut4 (AbCam) protein expression. Pellets were resuspended in Buffer B (Buffer A + 1% Triton X-100), homogenized through a 26g needle 5 times and by guest, on November 10, 2017
www.jlr.org Downloaded from incubated on ice for 15 minutes, and ultracentrifuged at 100,000g for 1 hour. The supernatants (plasma membranes) were saved for Western analysis of Glut4 protein expression.
Cytotoxicity, Apoptosis, and Necrosis Assays
To gauge level of cytotoxicity in response to fatty acid treatment, a lactate dehydrogenase (LDH) assay was performed using a kit from Promega according to the manufacturer's recommended instructions.
Additionally, Annexin V and propidium iodide (PI) staining were evaluated to quantify apoptosis and necrosis, respectively, using the Vibrant Apoptosis Kit (Invitrogen) according to the manufacturer's suggested protocol. Using this kit, apoptosis was quantified using flow-assisted cell sorting (FACS) using a BD Biosciences FACSCanto II flow cytometer, using 100 µM hydrogen peroxide or 1 µM paclitaxel (Sigma-Aldrich) as positive controls.
Mitochondrial Reactive Oxygen Species
Adipocytes were grown and differentiated on glass coverslips, then treated with fatty acids in 25 mM glucose for 7 days. MitoTracker Green (Invitrogen) was used to specifically label mitochondria based on mitochondrial membrane potential, and MitoSox Red (Invitrogen) was used to label mitochondrial superoxide in live cells. IBX was used as a positive control. Images were captured using a Nikon Eclipse 80i fluorescence microscope (40X objective) coupled with a Nikon Dx-QiMc camera (normalized to exposure time). In some experiments, secreted hydrogen peroxide was measured from the cell culture media using Amplex Red reagents from Invitrogen according to the suggested protocol, and presented as nM hydrogen peroxide normalized to total cellular protein.
Mitochondrial Isolation and 10E,12Z-CLA Quantification
Treated 3T3-L1 adipocytes were scraped into chilled Mitochondrial Isolation Buffer (MIB: 25 mM Tris (pH 7.4), 250 mM sucrose, 1 mM EDTA) and homogenized using 20 strokes of a Dounce homogenizer.
Nuclei were pelleted and discarded by brief centrifugation at 1000g, and mitochondria were then pelleted Data are presented as mean ± standard error of the mean (SEM). Each experiment was conducted in duplicate and repeated at least 3 times. Data were analyzed using paired student's t-test to determine differences between treatment groups, reaching statistical significance when p<0.05.
Results
10E,12Z-CLA reduces neutral lipid storage within cultured 3T3-L1 adipocytes.
Adipocytes grown in culture accumulate triglyceride-containing lipid droplets when exposed to excess glucose, certain fatty acids, or a combination of both. We have shown previously that certain saturated (laurate, palmitate, and stearate) and unsaturated (oleate) fatty acids induce such triglyceride accumulation, while polyunsaturated (docosahexaenoic and eicosapentaenoic acid) fatty acids prevent it (27) . Since 10E,12Z-CLA is purported to reduce adipose tissue mass (33, 34), we evaluated the adipocyte triglyceride storage in response to this trans fatty acid. Differentiated 3T3-L1 adipocytes were treated for 7 days with daily replenishment of 250 µM palmitate (PA, used as a positive control), 9Z,11E-CLA (negative control), or 10E,12Z-CLA in a 25 mM (high) glucose-containing medium. Lipid droplet and total cell size decreased after 10E,12Z-CLA treatment when compared to controls ( Figure 1A ). This decrease was seen in both low (5 mM) and high (25 mM) glucose conditions and was not reversed by the addition of excess palmitate (data not shown). Direct quantification of total intracellular triglyceride confirmed this effect of 10E,12Z-CLA ( Figure 1B ). These results support previous suggestions that 10E,12Z-CLA reduces triglyceride accumulation within cultured adipocytes (11) .
CPT -1α expression and fatty acid oxidation are increased in adipocytes treated with 10E,12Z-CLA.
The primary role of adipose tissue is to store excess ingested energy as triglyceride, which can be readily used by the body in times of need. Since 10E,12Z-CLA -treated adipocytes exhibit reduced lipid storage,
we examined an alternative pathway by which fatty acids are utilized: the fatty acid oxidation pathway.
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Fatty acid oxidation occurs inside mitochondria, comprised of two fatty acid-impermeable membranes.
For fatty acid oxidation to occur, FFA must freely diffuse into cells and become acylated into fatty acylCoA. Carnitine palmitoyl transferase I (CPT-1) facilitates fatty acyl-CoA transport across the outer mitochondrial membrane, and as such is the rate-limiting enzyme in the initiation of fatty acid oxidation.
We have modified a common method for measuring fatty acid oxidation in cultured adipocytes that takes advantage of the CO 2 released as a by-product of fatty acid oxidation. Using proliferator-activated receptor gamma (PPARγ), a nuclear receptor involved in adipogenesis, were not changed by 10E,12Z-CLA. In contrast, PPAR coactivator 1-alpha (PGC-1α), a transcriptional coactivator required for CPT-1 activation, and PPARδ, a nuclear receptor recently found to be involved in fatty acid oxidation (35, 36) , were significantly increased by 10E,12Z-CLA, while PPARα, which under nutrientpoor conditions stimulates uptake of fatty acids (37), was significantly decreased by 10E,12Z-CLA. Figure 2D ).
10E,12Z-CLA increases basal lipolysis in cultured adipocytes.
In order for fatty acid oxidation to occur, fatty acid substrate must be made available for shuttling through the mitochondria. One potential mechanism of increasing fatty acid availability is to enhance the lipolysis of stored triglyceride by adipocytes. To determine if lipolysis is increased by 10E,12Z-CLA treatment, glycerol was quantified in the culture medium after the 7 th day of replenished treatment. Basal lipolysis rates were increased by 10E,12Z-CLA, as shown in Figure 2E . However, 10E,12Z-CLA-treated adipocytes stimulated with 10 µM isoproterenol, known to induce lipolysis (38) , showed a reduction in lipolysis ( Figure 2F ), likely due to limited triglyceride availability in these cells.
10E,12Z-CLA reduces glucose uptake and consumption in cultured adipocytes.
Another potential mechanism by which adipocyte triglyceride storage could be decreased by 10E,12Z-CLA is by altered glucose uptake, consumption, and/or insulin signaling. As shown in Figure 3A, insulin-stimulated 3 H-2-deoxyglucose uptake was decreased in 10E,12Z-CLA-treated adipocytes in 25 mM glucose. In addition, glucose consumption monitored over the course of the 7 day 10E,12Z-CLA treatment period was decreased in 3T3-L1 adipocytes, beginning after only 2 days ( Figure 3B ).
Decreased plasma membrane expression of the major adipocyte glucose transporter, Glut4, resulted from 10E,12Z-CLA treatment ( Figure 3C ). Appropriate insulin signaling through Akt is essential for proper Glut4 surface expression and glucose uptake. Therefore, the phosphorylation state of Akt was evaluated to determine if reduced Glut4 expression results from impaired insulin signaling. Akt phosphorylation was not changed by 10E,12Z-CLA ( Figure 3D ), suggesting that these cells remain insulin sensitive.
10E,12Z-CLA induces inflammatory and chemotactic factor gene expression from cultured adipocytes,
which are potentiated by palmitate.
As previously reported, certain fatty acids such as palmitate induce an inflammatory response from cultured adipocytes, including cytokines such as interleukin 6 (IL-6) (39), and monocyte chemotactic factors such as serum amyloid A-3 (SAA3) and monocyte chemotactic protein-1 (MCP-1) (27) .
However, LA (18:2), the all-cis isomer of CLA and a polyunsaturated fatty acid, does not exert proinflammatory or chemotactic effects on adipocytes (27) . We therefore examined inflammatory and chemotactic factor gene expression from 10E,12Z-CLA-treated adipocytes. Cells grown in 25 mM glucose expressed significantly higher levels of IL-6 and MCP-1 when normalized to 5 mM glucose controls. Moreover, gene expression levels of IL-6 and MCP-1 were further increased by the addition of 10E,12Z-CLA in 25 mM glucose, with no differences when c9,t11 CLA was added ( Figure 4A-B) . These pro-inflammatory responses to 10E,12Z-CLA were not associated with apoptosis or necrosis (data not shown), and are dose dependent ( Figure 4C-D) .
A diet containing CLA would likely also contain saturated fatty acids such as palmitate (PA). PA is known to induce a toll-like receptor 4 (TLR4)-dependent inflammatory response in adipocytes (27) .
Since palmitate did not affect 10E,12Z-CLA-induced fatty acid oxidation as described above, the combined effect of palmitate and 10E,12Z-CLA on adipocyte inflammatory gene expression was of interest. As expected, adipocyte treatment with either palmitate or 10E,12Z-CLA elicited a proinflammatory response. However, when both fatty acids (250 µM each) were included together in the 7 day treatment, pro-inflammatory gene expression levels were nearly double, suggesting an additive response ( Figure 4A-B) . This additive effect was replicated when both fatty acids were used in combination at half the original dose (125 µM each), for a total fatty acid exposure of 250 µM (data not shown), suggesting an additive inflammatory response via different signaling pathways.
10E,12Z-CLA is taken up by mitochondria and induces mitochondrial ROS
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Fatty acid oxidation takes place inside mitochondria, of which white adipocytes typically have few (40) .
Our data clearly indicates that fatty acid oxidation is increased in 3T3-L1 adipocytes following 10E,12Z- In an effort to determine whether 10E,12Z-CLA becomes oxidized in the mitochondria, we isolated mitochondrial lipids and quantified 18:2 moieties using mass spectrometry. 10E,12Z-CLA was used as an internal standard, but was indistinguishable from other 18:2 lipids (LA, 9Z,11E-CLA, data not shown)
as they share the same mass. As shown in Figure 5B , a baseline level of 18:2 was detected in control cells, presumably from serum in the culture medium. However, a representative spectrum resulting from 10E,12Z-CLA treatment shows a much stronger, sharper peak ( Figure 5C ). When area under the curve is quantified, 10E,12Z-CLA-treated cells show a peak that is 2X larger ( Figure 5D ). Since serum levels and fatty acid uptake are the same in both treatments ( Figure 2D ), this suggests that the extra peak area could come from 10E,12Z-CLA incorporation into mitochondria.
With such dramatic effects on mitochondrial function, it is possible that 10E,12Z-CLA is inefficiently oxidized and directly disrupts mitochondrial respiration. To test whether this occurred acutely, cultured adipocytes were exposed to high doses of 10E,12Z-CLA and control fatty acids (500 μM for up to 45 minutes), and oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) were measured using a Seahorse XF96 system. OCR increases within minutes of the addition of either 9Z,10E-CLA or 10E,12Z-CLA ( Figure 5E ), and is not altered by pre-treatment with etomoxir, a potent inhibitor of fatty acid oxidation ( Figure 5G ). Concurrently, ECAR decreases dramatically upon addition of BSA control, 9Z,10E-CLA and 10E,12Z-CLA, also independently of etomoxir ( Figure 5F and 5H).
These findings suggest that 9Z,10E-CLA and 10E,12Z-CLA have immediate effects on mitochondrial respiration, and both impact glycolytic pathways. Furthermore, both 9Z,10E-CLA and 10E,12Z-CLA increase secreted hydrogen peroxide equally ( Figure 5I ). Pre-treating cells with etomoxir did not attenuate this acute hydrogen peroxide secretion, suggesting that these acute ROS do not derive from mitochondria. Overall, these data suggest that while 10E,12Z-CLA does have acute effects on mitochondrial respiration and ROS production, its effects do not differ markedly from those of 9Z,10E-CLA.
Antioxidants attenuate 10E,12Z-CLA-induced inflammation with modest effects on fatty acid oxidation
To determine whether inflammation and mitochondrial ROS influence fatty acid oxidation, antioxidants NAC and catalase were included in all treatments. To confirm attenuation of oxidative stress by these antioxidants, we observed a decrease in gene expression of Nrf2, a transcription factor stimulated by oxidative stress ( Figure 6A ). As shown in Figure 6B -C, both antioxidants also attenuated 10E,12Z-CLAinduced IL-6 and MCP-1 gene expression. However, only NAC significantly reduced fatty acid oxidation ( Figure 6D ) and CPT-1α gene expression ( Figure 6E ), and only partially. This suggests that the inflammatory response to 10E,12Z-CLA is not likely driving fatty acid oxidation.
Disrupting fatty acid oxidation attenuates the adipocyte inflammatory response to 10E,12Z-CLA and restores glucose consumption and lipid storage.
With enhanced fatty acid oxidation and lipolysis, and the absence of any noticeable apoptosis, the inflammatory response to 10E,12Z-CLA could reflect the early stages of a starvation response. To determine if the 10E,12Z-CLA-induced inflammation is a response to the enhanced fatty acid oxidation, etomoxir, a CPT-1 inhibitor and hence an inhibitor of fatty acid oxidation, was included in all treatments.
Etomoxir-CoA has been shown to bind CPT-1 with high affinity, thereby preventing mitochondrial and mitochondrial superoxide generation ( Figure 7E ). Moreover, etomoxir attenuated 10E,12Z-CLAinduced IL-6 and MCP-1 gene expression and mitochondrial superoxide production ( Figure 7C-D) .
Furthermore, while glucose uptake and consumption rapidly decreased with 10E,12Z-CLA treatment, including etomoxir restored both ( Figure 8A-B) , and enabled adipocytes to store more triglyceride ( Figure   8C ), suggesting that cells in which fatty acid oxidation is prevented can revert back to glucose utilization and lipid storage.
Lipolysis is not involved in the lipid catabolic phenotype induced by 10E,12Z-CLA
To determine if lipolysis of lipid stores in cultured adipocytes is essential for 10E,12Z-CLA-induced fatty acid oxidation, we included the general lipase inhibitor orlistat in all treatments. As expected, lipolysis was dramatically reduced ( Figure 9A ), but surprisingly fatty acid oxidation and CPT-1α gene expression were unchanged ( Figure 9B-C) , and lipid uptake remained the same (not shown). This suggests that fatty acids utilized for fatty acid oxidation in 10E,12Z-CLA-treated adipocytes do not originate from lipid stores, but likely are directly imported into mitochondria upon cellular entry.
Discussion
In this work we present a novel adipocyte phenotype generated by the chronic exposure of cultured adipocytes to 10E,12Z-CLA, a naturally occurring trans fatty acid with purported weight loss properties.
We have shown that such exposure decreases triglyceride storage by enhancing fatty acid oxidation and lipolysis, while concurrently reducing glucose uptake and consumption. The delipidation of these cells is coupled with enhanced inflammatory gene expression and mitochondrial ROS, which become attenuated when the lipid storage capacity is restored by inhibiting fatty acid oxidation. In addition, these cells remain sensitive to insulin, despite high levels of inflammatory gene expression. This phenotype is unique in that it describes a cell that is normally engineered to store lipid that has been converted into one that burns fatty acids. Other cell types such as hepatocytes, cardiac myocytes, and skeletal muscle cells frequently utilize fatty acid substrates released from adipose triglyceride stores as a quick energy source when glucose is unavailable, but white adipocytes do not typically utilize this pathway for their own use (42) . As such, we could speculate that fatty acid oxidation might have different effects in different tissues, and based on the data presented herein might not necessarily be beneficial to white adipocytes.
Considerable research has been done examining the delipidating effects of 10E,12Z-CLA, but with conflicting results. While a few human supplementation studies suggest that 10E,12Z-CLA induces insulin resistance (17, 43) , many others do not find such a correlation (34, (44) (45) (46) . Similarly, published in vitro studies also present contradicting results, with some suggesting that 10E,12Z-CLA reduces glucose uptake (11, 47) and others that it enhances it (48), while some suggest that 10E,12Z-CLA induces lipolysis and/or fatty acid oxidation (48) , and others that it suppresses these responses (25, (49) (50) (51) . Some of these discrepancies can be attributed to differences in experimental design, such as length of treatment, adipocyte differentiation status, isomer combinations used, or fatty acid dose. In our study, 7 days of 250 μM 10E,12Z-CLA treatment were necessary to induce functional fatty acid oxidation, despite increased CPT-1α and inflammatory gene expression with lower doses and after only 2 days. There is mounting evidence that 10E,12Z-CLA does not circulate at measurable levels in human plasma (52, 53) , but accumulates over time within adipose tissue (54, 55) . Therefore, the chosen dose of 250 μM is within the range expected within adipocytes following dietary supplementation. One particular study also examined long-term exposure of adipocytes to 9Z,11E-and 10E,12Z-CLA in vitro, and showed enhancement of lipid catabolism genes by 10E,12Z-CLA after 8 days (25) . With such inconsistent findings, it was necessary to determine which metabolic pathways were induced in our in vitro model of chronic 10E,12Z-CLA exposure.
In adipocytes, the level of lipid storage at any given time is regulated by a balance between lipogenesis and lipolysis, depending on the immediate demands of the body. It has recently been shown that by guest, on November 10, 2017
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10E,12Z-CLA induces a defect in lipid storage in cultured adipocytes (56) , and in our in vitro system the cells could resort to fatty acid oxidation to avoid lipotoxicity. Our results corroborate this finding, as we suggest herein that fatty acids entering the adipocyte do not become esterified, and are instead quickly shuttled through mitochondrial fatty acid oxidation. It has been suggested by Henique et al. that a shift towards fatty acid oxidative metabolism could be a protective mechanism against apoptosis (57).
However, in our study we have shown that 7 days of 10E,12Z-CLA treatment does not induce measurable apoptosis or necrosis. Furthermore, our observation that additional fatty acid substrate (palmitate) did not further enhance fatty acid oxidation suggests that either the cells can appropriately tolerate the excess lipid load, or the fatty acid oxidation rate is already maximal.
While enhanced fatty acid oxidation in adipocytes might provide an ideal mechanism of reduced visceral adiposity, it comes at the expense of enhanced inflammation and generation of mitochondrial ROS.
However, it is interesting that this adipocyte phenotype is reversible. By inhibiting fatty acid oxidation, the cells revert back to glucose utilization and inflammation is reduced. The Randle cycle ("glucose-fatty acid cycle") describes the fuel flux between tissues, specifically the competition between glucose and fatty acids for their oxidation in muscle and adipose tissue. Randle proposed that fatty acids inhibit glucose oxidation, leading to what is now termed insulin resistance (58, 59) . What is intriguing about our results is that of all the fatty acids examined herein, only 10E,12Z-CLA seems to push the glucosefatty acid cycle towards fatty acid oxidation, suggesting a very specific effect of this particular fatty acid.
It appears that the stereochemistry of 10E,12Z-CLA, compared with structurally similar CLA isomers, enables it to exert these unique effects.
While it has been suggested previously that 10E,12Z-CLA induces adipocyte inflammation and reactive oxygen species generation by a Ca 2+ -dependent mechanism (60, 61) , it is somewhat surprising that this polyunsaturated fatty acid exerts pro-inflammatory effects. Previous work in our laboratory and others suggests that the majority of monounsaturated and polyunsaturated fatty acids are anti-inflammatory (27, 62) , likely due to their ability to serve as PPARγ ligands (63) . Interestingly, PPARδ gene expression is increased in response to 10E,12Z-CLA, suggesting a highly novel alternative pathway by which this fatty acid induces PPAR-dependent inflammation. In comparison to palmitate, a fatty acid whose proinflammatory nature has been well characterized, our data suggests that 10E,12Z-CLA activates the same pro-inflammatory pathways, but likely through different mechanisms. The additive pro-inflammatory effect of 10E,12Z-CLA and palmitate supports this notion. Furthermore, our laboratory has recently shown that palmitate induces chemotactic factor expression by generating NOX4-dependent ROS (28), while 10E,12Z-CLA generates mitochondrial-specific ROS. Moreover, palmitate does not have significant effects on lipid metabolism in cultured adipocytes, while 10E,12Z-CLA induces a delipidated, glucose-deprived state resembling starvation. Further work is warranted to tease apart these potentially divergent pro-inflammatory pathways.
Several possible mechanisms could describe the unique adipocyte phenotype generated by exposure to 10E,12Z-CLA. As previously mentioned, the enhanced fatty acid oxidation could be a secondary result of reduced glucose uptake. With reduced intracellular glucose, fatty acids cannot be stored properly as neutral triglyceride, and to avoid lipotoxicity and cellular starvation they are utilized for fatty acid oxidation. However, disrupting fatty acid oxidation restores glucose uptake, so it is likely that the reduced glucose uptake is instead a metabolic consequence of enhanced fatty acid oxidation. The mitochondrial ROS could be the result of an overloaded mitochondrial system engaged in excessive levels of fatty acid oxidation, which leads to increased inflammation. In addition, AMP-activated protein kinase (AMPK) has recently been shown to be activated by 10E,12Z-CLA (24, 64) . AMPK is a master switch regulating cellular metabolism by promoting lipid catabolism over storage (65) , is activated by ROS (66), and is also involved in activation of uncoupling proteins (67), the fatty acid oxidation pathway and maintenance of insulin sensitivity (68).
To our knowledge, this is the first time that 10E,12Z-CLA has been shown to induce substantial pathophysiological changes in adipocyte mitochondria. Typically in adipocytes, excessive nutrients (i.e.-glucose and fatty acids) reduce mitochondrial biogenesis and increase ROS, leading to insulin resistance.
ROS then reduce oxygen consumption, block fatty acid oxidation, and promote lipogenesis (69) .
However, with 10E,12Z-CLA treatment, mitochondrial ROS and reduced glucose uptake are accompanied by enhanced fatty acid oxidation, attenuated lipogenesis, and maintained insulin sensitivity, which seems paradoxical. Furthermore, mitochondrial dysfunction in adipose tissue has been linked to impaired fatty acid oxidation (70) and insulin resistance (71), yet with 10E,12Z-CLA exposure we have
shown that adipocyte mitochondria are fully capable of oxidizing fatty acids and these cells are insulin sensitive. We speculate that in this case, excessive 10E,12Z-CLA cannot be stored properly in adipocytes, so it must be eliminated by fatty acid oxidation to avoid lipotoxicity. Due to the Randle Cycle, glucose uptake and utilization is impaired due to the energetic preference of fatty acids.
Inflammatory cytokines, chemokines and mitochondrial ROS are probably generated due to an overloaded mitochondrial system, since blocking fatty acid oxidation reduces these but doesn't affect mitochondrial gene expression. Furthermore, UCP-2 expression is likely increased as a compensatory mechanism to dissipate excessive mitochondrial ROS (72, 73) , potentially mediated by PPARδ (74).
Recently Kisminsky et al. showed that mice overexpressing adipocyte mitoNEET, a mitochondrial membrane protein, exhibit increased fatty acid oxidation in adipose tissue with concurrent increases in oxidative stress and glucose intolerance (75) , suggesting that the adipocyte phenotype described herein is plausible in vivo. Moreover, it is possible that 10E,12Z-CLA might accumulate within the mitochondrial matrix and/or be incorporated into mitochondrial lipids, thereby altering components of mitochondrial respiratory pathways over time. Cardiolipin is a specific inner mitochondrial membrane phospholipid required for the optimal activity of several enzymes involved in cellular energy metabolism. Because dietary lipids can easily alter the phospholipid composition of cellular membranes, and due to its central role in mitochondrial energetics, alterations in cardiolipin composition could substantially alter mitochondrial function. In addition, the major fatty acid precursor for cardiolipin formation is linoleic acid (76) , and because 10E,12Z-CLA is structurally similar and has profound effects on mitochondrial metabolism, it seems likely that it could also incorporate itself into cardiolipin. Furthermore, the particular fatty acid composition of cardiolipin has been shown to have profound effects on mitochondrial function in cardiac myocytes (77) . While acute treatment of adipocytes with 10E,12Z-CLA did not adversely affect mitochondrial metabolism, chronic treatment might ultimately alter cardiolipin content to facilitate the mitochondrial phenotype described herein.
In summary Data were normalized to an internal standard (B2M) and normalized to control, presented as mean ± SEM from three independent experiments. PA: palmitate. *P<0.05 from control, #P<0.05 from PA. 
